PRESS RELEASE published on 11/19/2024 at 07:30, 1 year 8 months ago Nicox Announces Publication of the Adaptive Design Period of the NCX 470 Mont Blanc Phase 3 Trial Nicox announces the publication of the adaptive design period of the NCX 470 Mont Blanc Phase 3 trial, selecting 0.1% concentration due to better intraocular pressure reduction and safety profile Phase 3 Trial Ophthalmology Nicox NCX 470 Adaptive Design
BRIEF published on 10/14/2024 at 07:35, 1 year 10 months ago Nicox and Soleus sign $16.5 million financing agreement Funding Nicox NCX 470 Soleus Capital VYZULTA
PRESS RELEASE published on 10/14/2024 at 07:30, 1 year 10 months ago Nicox and Soleus Sign $16.5 million Royalty and Equity Financing Nicox and Soleus sign $16.5 million royalty and equity financing agreement, reducing debt burden and financing into Q3 2025. Topline results expected in Q3 2025 for NCX 470 Denali Phase 3 trial Equity Financing Nicox NCX 470 Soleus Royalty
BRIEF published on 09/18/2024 at 07:35, 1 year 10 months ago Nicox Announces Approval of ZERVIATE in China China Ophthalmology Nicox ZERVIATE Ocumension
PRESS RELEASE published on 09/18/2024 at 07:30, 1 year 10 months ago Nicox Announces Approval of ZERVIATE in China Nicox announces approval of ZERVIATE in China by partner Ocumension Therapeutics for ocular itching, adding royalty revenue stream. Launch expected to boost market penetration China Approval Nicox ZERVIATE Ocular Itching
BRIEF published on 09/04/2024 at 07:35, 1 year 11 months ago Nicox Appoints Christine Placet as Director; Michele Garufi Retires from Board of Directors Board Of Directors Ophthalmology Christine Placet Nicox Michele Garufi
PRESS RELEASE published on 09/04/2024 at 07:30, 1 year 11 months ago Nicox Appoints Christine Placet to Board of Directors; Michele Garufi steps down from Board Nicox appoints Christine Placet to Board of Directors as Michele Garufi steps down after over 25 years. Entire Nicox Board renewed for strategic direction support Board Of Directors Biotech Industry Christine Placet Nicox Michele Garufi
BRIEF published on 07/19/2024 at 07:35, 2 years ago Nicox: Participation in upcoming conferences Conférences 2024 Investments Ophthalmology Nicox
PRESS RELEASE published on 07/19/2024 at 07:30, 2 years ago Nicox announces attendance at upcoming conferences Nicox announces attendance at upcoming international conferences, including H.C. Wainwright 4th Annual Ophthalmology Virtual Conference and AAO 2024 Clinical Development International Conférences Ophthalmology Nicox
BRIEF published on 07/18/2024 at 07:35, 2 years ago Nicox Provides Second Quarter 2024 Update Q2 2024 Financial Update Ophthalmology Nicox NCX 470
Published on 08/15/2026 at 00:50, 5 hours 10 minutes ago Revive Therapeutics Reports Grant of Options
Published on 08/15/2026 at 00:15, 5 hours 45 minutes ago Full Circle Lithium Announces Closing of Private Placement
Published on 08/14/2026 at 23:45, 6 hours 15 minutes ago AI/ML Innovations Inc. Announces Proposed Private Placement
Published on 08/14/2026 at 23:25, 6 hours 35 minutes ago NuRAN Wireless Closes $7.6 Million Financing
Published on 08/14/2026 at 23:00, 7 hours ago Medicure Reports Financial Results for Quarter Ended June 30, 2026 and Schedules August 17, 2026 Conference Call
Published on 08/14/2026 at 18:15, 11 hours 45 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 08/14/2026 at 16:05, 13 hours 55 minutes ago GATORADE WELCOMES AITANA BONMATÍ TO TEAM GATORADE AHEAD OF THE NEW FOOTBALL SEASON
Published on 08/14/2026 at 15:29, 14 hours 31 minutes ago Tradegate AG publishes its half-year report
Published on 08/14/2026 at 15:02, 14 hours 57 minutes ago Form 8.3 - The Vanguard Group, Inc.: Prologis, Inc.
Published on 08/10/2026 at 18:00, 4 days 12 hours ago AXA: Information relating to the number of voting rights and shares making up the share capital on 31/07/2026
Published on 08/10/2026 at 11:53, 4 days 18 hours ago GUILLEMOT CORPORATION | Information regarding the total number of voting rights and shares 31/07/2026
Published on 08/10/2026 at 11:36, 4 days 18 hours ago GUILLEMOT CORPORATION| Weekly report share buyback from August 3 to August 7 2026
Published on 08/10/2026 at 09:22, 4 days 20 hours ago Number of shares and voting rights - July 2026 (In French only)
